Characterizing generalized anxiety: Temporal and symptomatic thresholds

被引:35
作者
Bienvenu, OJ
Nestadt, G
Eaton, WW
机构
[1] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Mental Hyg, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
关键词
D O I
10.1097/00005053-199801000-00008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We compared demographic and comorbidity profiles of subjects with varying levels of anxiety pathology to test if the clinical characteristics of generalized anxiety disorder (GAD) subjects differed from those of other subjects with generalized anxiety. Using Diagnostic Interview Schedule data from the 1993 follow-up study of the Baltimore cohort of the Epidemiologic Catchment Area Program, we divided subjects into the following five mutually exclusive symptom categories: a) DSM-III-R GAD; b) 6 months of worry or anxiety with six associated symptoms; c) 1 month of anxiety with or d) without six symptoms; and e) no anxiety. The first three groups were homogeneous with regard to demographic and comorbidity profiles, but their profiles differed from those of subjects with no anxiety or fewer than six symptoms. Thus, requiring six symptoms produced a group with a particular epidemiologic profile. Neither the nature of the subjects' worries nor the duration of symptoms influenced this profile. These results are discussed in terms of GAD's construct validity.
引用
收藏
页码:51 / 56
页数:6
相关论文
共 36 条
[21]   Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey [J].
Kessler, RC ;
Nelson, CB ;
McGonagle, KA ;
Liu, J ;
Swartz, M ;
Blazer, DG .
BRITISH JOURNAL OF PSYCHIATRY, 1996, 168 :17-30
[22]   DELINEATION OF 2 DRUG-RESPONSIVE ANXIETY SYNDROMES [J].
KLEIN, DF .
PSYCHOPHARMACOLOGIA, 1964, 5 (06) :397-408
[23]   PSYCHIATRIC EPIDEMIOLOGY IN KOREA .2. URBAN AND RURAL DIFFERENCES [J].
LEE, CK ;
KWAK, YS ;
YAMAMOTO, J ;
RHEE, H ;
KIM, YS ;
HAN, JH ;
CHOI, JO ;
LEE, YH .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1990, 178 (04) :247-252
[24]   EVALUATION OF THE RATINGS COMPRISING THE ASSOCIATED SYMPTOM CRITERION OF DSM-III-R GENERALIZED ANXIETY DISORDER [J].
MARTEN, PA ;
BROWN, TA ;
BARLOW, DH ;
BORKOVEC, TD ;
SHEAR, MK ;
LYDIARD, RB .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1993, 181 (11) :676-682
[25]  
MASSION AO, 1993, AM J PSYCHIAT, V150, P600
[26]   Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: Results of an international task force [J].
Merikangas, KR ;
Angst, J ;
Eaton, W ;
Canino, G ;
RubioStipec, M ;
Wacker, H ;
Wittchen, HU ;
Andrade, L ;
Essau, C ;
Whitaker, A ;
Kraemer, H ;
Robins, LN ;
Kupfer, DJ .
BRITISH JOURNAL OF PSYCHIATRY, 1996, 168 :58-67
[27]  
MORAS K, 1996, DSM 4 SOURCEBOOK, V2, P607
[28]   DSM-III COMPULSIVE PERSONALITY-DISORDER - AN EPIDEMIOLOGIC SURVEY [J].
NESTADT, G ;
ROMANOSKI, AJ ;
BROWN, CH ;
CHAHAL, R ;
MERCHANT, A ;
FOLSTEIN, MF ;
GRUENBERG, EM ;
MCHUGH, PR .
PSYCHOLOGICAL MEDICINE, 1991, 21 (02) :461-471
[29]  
NOYES R, 1987, AM J PSYCHIAT, V144, P1019
[30]  
ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381